Literature DB >> 25316865

The new polio eradication end game: rationale and supporting evidence.

Roland W Sutter1, Lauren Platt1, Ondrej Mach1, Hamid Jafari1, R Bruce Aylward1.   

Abstract

Polio eradication requires the removal of all polioviruses from human populations, whether wild poliovirus or those emanating from the oral poliovirus vaccine (OPV). The Polio Eradication & Endgame Strategic Plan 2013-2018 provides a framework for interruption of wild poliovirus transmission in remaining endemic foci and lays out a plan for the new polio end game, which includes the withdrawal of Sabin strains, starting with type 2, and the introduction of inactivated poliovirus vaccine, for risk mitigation purposes. This report summarizes the rationale and evidence that supports the policy decision to switch from trivalent OPV to bivalent OPV and to introduce 1 dose of inactivated poliovirus vaccine into routine immunization schedules, and it describes the proposed implementation of this policy in countries using trivalent OPV.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  eradication; poliomyelitis; vaccination

Mesh:

Substances:

Year:  2014        PMID: 25316865     DOI: 10.1093/infdis/jiu222

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

Review 1.  Vaccines against enteric infections for the developing world.

Authors:  Cecil Czerkinsky; Jan Holmgren
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

2.  Human Enterovirus Diversity by Next-Generation Sequencing Analysis in Urban Sewage Samples From Buenos Aires Metropolitan Area, Argentina: A Retrospective Study.

Authors:  A Lizasoain; D Mir; M Victoria; M E Barrios; M D Blanco-Fernández; N Rodríguez-Osorio; S Nates; D Cisterna; V A Mbayed; R Colina
Journal:  Food Environ Virol       Date:  2021-03-06       Impact factor: 2.778

3.  Live attenuated enterovirus vaccine (OPV) is not associated with islet autoimmunity in children with genetic susceptibility to type 1 diabetes: prospective cohort study.

Authors:  Hanna Viskari; Sami Oikarinen; Sanna Hoppu; Tytti Vuorinen; Heini Huhtala; Jorma Toppari; Riitta Veijola; Jorma Ilonen; Mikael Knip; Heikki Hyöty
Journal:  Diabetologia       Date:  2017-09-02       Impact factor: 10.122

4.  The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses.

Authors:  Eve-Isabelle Pécheur; Viktoriya Borisevich; Peter Halfmann; John D Morrey; Donald F Smee; Mark Prichard; Chad E Mire; Yoshihiro Kawaoka; Thomas W Geisbert; Stephen J Polyak
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

5.  Immunogenicity of Different Routine Poliovirus Vaccination Schedules: A Randomized, Controlled Trial in Karachi, Pakistan.

Authors:  Ali F Saleem; Ondrej Mach; Mohammad T Yousafzai; Asia Khan; William C Weldon; M Steven Oberste; Syed S Zaidi; Muhammad M Alam; Farheen Quadri; Roland W Sutter; Anita K M Zaidi
Journal:  J Infect Dis       Date:  2018-01-17       Impact factor: 5.226

Review 6.  Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors.

Authors:  Daniel E Velasquez; Umesh Parashar; Baoming Jiang
Journal:  Expert Rev Vaccines       Date:  2017-12-29       Impact factor: 5.217

7.  Seroprevalence of Anti-polio Antibodies in Children From Polio High-risk Areas of Pakistan: A Cross-Sectional Survey 2015-2016.

Authors:  Imtiaz Hussain; Ondrej Mach; Atif Habib; Zaid Bhatti; Zamir Suhag; M Steven Oberste; William C Weldon; Roland W Sutter; Sajid B Soofi; Zulfiqar A Bhutta
Journal:  Pediatr Infect Dis J       Date:  2017-09       Impact factor: 3.806

8.  Achieving High Poliovirus Antibody Seroprevalence in Areas at Risk of Vaccine-Derived Poliovirus Transmission-Niger Experience.

Authors:  Sani Ousmane; Dan Dano Ibrahim; Ajay Goel; William S Hendley; Bernardo A Mainou; Tess Palmer; Aissata Diaha; Sharon A Greene; Ondrej Mach
Journal:  Open Forum Infect Dis       Date:  2021-05-06       Impact factor: 3.835

9.  Poliovirus Type 2 Seroprevalence Following Full- or Fractional-Dose Inactivated Poliovirus Vaccine in the Period After Sabin Type 2 Withdrawal in Sri Lanka.

Authors:  Deepa Gamage; Ondrej Mach; Samitha Ginige; William C Weldon; M Steven Oberste; Visalakshi Jeyaseelan; Roland W Sutter
Journal:  J Infect Dis       Date:  2019-05-24       Impact factor: 7.759

10.  One-Year Decline of Poliovirus Antibodies Following Fractional-Dose Inactivated Poliovirus Vaccine.

Authors:  Ali Faisal Saleem; Ondrej Mach; Mohammad Tahir Yousafzai; Zaubina Kazi; Attaullah Baig; Muhammad Sajid; Vishali Jeyaseelan; Roland W Sutter; Anita K M Zaidi
Journal:  J Infect Dis       Date:  2021-04-08       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.